2017. A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients. International Journal of Biomedical and Advance Research. 8, 11 (Nov. 2017), 407–415. DOI:https://doi.org/10.7439/ijbar.v8i11.4474.